ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Trade Issues Supply chain & Buy American issues (COVID-19 related) Importation
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| MORGAN BRADLEY-JONES | — |
| HELEN DWIGHT | — |
| THADDEUS FLOOD New | — |
| CAROLINE QUAT | NA |
| STEPHANIE WISWALL New | — |
Health Issues HCR
Value of Prescription Drugs Drug Pricing Transparency Personalized Medicine Diagnostics S. 1895, Lower Health Care Costs Act COVID-19 Vaccine and Therapy Development COVID-19 response packages Telehealth
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| MORGAN BRADLEY-JONES | — |
| HELEN DWIGHT | — |
| THADDEUS FLOOD New | — |
| CAROLINE QUAT | NA |
| STEPHANIE WISWALL New | — |
Medicare/Medicaid MMM
Medicare Part D Coverage and Reimbursement Medicare Part D Non-Interference Legislative proposals to change Medicare Part D Medicare Part B coverage and reimbursement Changes to the Medicaid Drug Rebate Program (AMP Cap) Medicaid drug pricing reporting H.R. 107, To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs ESRD PPS, Medicare coverage ANPRM International Pricing Index Model for Medicare Part B Drugs Proposed Rule: Medicaid Program: Establishing Minimum Standards in Medicaid State Drug Utilization Value Based Arrangements
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| MORGAN BRADLEY-JONES | . |
| HELEN DWIGHT | — |
| THADDEUS FLOOD New | — |
| CAROLINE QUAT | NA |
| STEPHANIE WISWALL New | — |
Pharmacy PHA
Medicare Part D coverage and reimbursement Value of Prescription Drugs Innovative Payment Model Price Transparency Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program International Pricing Index Model (IPI) H.R. 1499, Protecting Consumer Access to Generic Drugs Act S. 1416, Affordable prescriptions for Patients Act S. 64, H.R. 2375, Preserve Access to Affordable Generics and Biosimilars Act NPRM: Importation of Prescription drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| MORGAN BRADLEY-JONES | — |
| HELEN DWIGHT | — |
| THADDEUS FLOOD New | — |
| CAROLINE QUAT | NA |
| STEPHANIE WISWALL New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.